Insulin resistance in Type 2 diabetes and obesity: implications for endothelial function

References

• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract.87, 4–14 (2010).
   PubMed Web of Science ®Google Scholar
• Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet368, 29–36 (2006).
   PubMed Web of Science ®Google Scholar
• Madala MC, Franklin BA, Chen AY et al. Obesity and age of first non-ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol.52, 979–985 (2008).
   PubMed Web of Science ®Google Scholar
• Pyorala M, Miettinen H, Laakso M, Pyorala K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation98, 398–404 (1998).
   PubMed Web of Science ®Google Scholar
• Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation113, 1888–1904 (2006).
   PubMed Web of Science ®Google Scholar
• Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest.100, 2153–2157 (1997).
   PubMed Web of Science ®Google Scholar
• Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation101, 1899–1906 (2000).
   PubMed Web of Science ®Google Scholar
• Laine H, Yki-Jarvinen H, Kirvela O et al. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J. Clin. Invest.101, 1156–1162 (1998).
   PubMed Web of Science ®Google Scholar
• Steinberg HO Chaker H, Leaming R et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J. Clin. Invest.97, 2601–2610 (1996).
   PubMed Web of Science ®Google Scholar
• Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol.27, 567–574 (1996).
   PubMed Web of Science ®Google Scholar
• Williams IL, Chowienczyk PJ, Wheatcroft SB et al. Endothelial function and weight loss in obese humans. Obes. Surg.15, 1055–1060 (2005).
   PubMed Web of Science ®Google Scholar
• Balletshofer BM, Rittig K, Enderle MD et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with Type 2 diabetes in association with insulin resistance. Circulation101, 1780–1784 (2000).
   PubMed Web of Science ®Google Scholar
• Murphy C, Kanaganayagam GS, Jiang B et al. Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler. Thromb. Vasc. Biol.27, 936–942 (2007).
   PubMed Web of Science ®Google Scholar
• Stern MP. Diabetes and cardiovascular disease. The ‘common soil’ hypothesis. Diabetes44, 369–374 (1995).
   PubMed Web of Science ®Google Scholar
• Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem.278, 45021–45026 (2003).
   PubMed Web of Science ®Google Scholar
• Zhang H, Park Y, Zhang C. Coronary and aortic endothelial function affected by feedback between adiponectin and tumor necrosis factor-α in Type 2 diabetic mice. Arterioscler. Thromb. Vasc. Biol.30, 2156–2163 (2010).
   PubMedGoogle Scholar
• Hotamisligil GS. Inflammation and metabolic disorders. Nature444, 860–867 (2006).
   PubMed Web of Science ®Google Scholar
• Bhagat K. Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation96, 3042–3047 (1997).
   PubMed Web of Science ®Google Scholar
• Wang P, Ba ZF, Chaudry IH. Administration of tumor necrosis factor-α in vivo depresses endothelium-dependent relaxation. Am. J. Physiol.266, 2535–2541 (1994).
   PubMedGoogle Scholar
• Barbarroja N, López-Pedrera R, Mayas MD et al. The obese healthy paradox: is inflammation the answer? Biochem. J.430, 141–149 (2010).
   PubMed Web of Science ®Google Scholar
• Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes46, 3–10 (1997).
   PubMed Web of Science ®Google Scholar
• Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome – an allostatic perspective. Biochim. Biophys. Acta1801(3), 338–349 (2010).
   PubMed Web of Science ®Google Scholar
• Roden M, Price TB, Perseghin G et al. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest.97(12), 2859–2865 (1996).
   PubMed Web of Science ®Google Scholar
• Erion DM, Shulman GI. Diacylglycerol-mediated insulin resistance. Nat. Med.16, 400–402 (2010).
   PubMed Web of Science ®Google Scholar
• de Man FH, Weverling-Rijnsburger AW, van der Laarse A. Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. Arterioscler. Thromb. Vasc. Biol.20, 744–750 (2000).
   PubMed Web of Science ®Google Scholar
• Steinberg HO, Tarshoby M, Monestel R et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J. Clin. Invest.100, 1230–1239 (1997).
   PubMed Web of Science ®Google Scholar
• Davda RK, Stepniakowski KT, Lu G et al. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension26(5), 764–770 (1995).
   PubMed Web of Science ®Google Scholar
• Inoguchi T, Li P, Umeda F et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes49, 1939–1945 (2000).
   PubMed Web of Science ®Google Scholar
• Kuboki K, Jiang ZY, Takahara N et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation101, 676–681 (2000).
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Fleming I, Fisslthaler B et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature399, 601–605 (1999).
   PubMed Web of Science ®Google Scholar
• Kanai F, Ito K, Todaka M et al. Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase. Biochem. Biophys. Res. Commun.195, 762–768 (1993).
   PubMedGoogle Scholar
• Bjornholm M, Kawano Y, LehtihetM, Zierath JR. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes46, 524–527 (1997).
   PubMed Web of Science ®Google Scholar
• Cusi K, Maezono K, Osman A et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J. Clin. Invest.105, 311–320 (2000).
   PubMed Web of Science ®Google Scholar
• Montagnani M, Quon MJ. Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension. Diabetes Obes. Metab.2, 285–292 (2000).
   PubMed Web of Science ®Google Scholar
• Jiang ZY, Lin YW, Clemont A et al. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J. Clin. Invest.104(4), 447–457 (1999).
   PubMed Web of Science ®Google Scholar
• Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation113, 1888–1904 (2006).
   PubMed Web of Science ®Google Scholar
• Duncan ER, Walker SJ, Ezzat VA et al. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species. Am. J. Physiol. Endocrinol. Metab.293, E1311–E1319 (2007).
   PubMed Web of Science ®Google Scholar
• Wheatcroft SB, Shah AM, Li JM et al. Preserved glucoregulation but attenuation of the vascular actions of insulin in mice heterozygous for knockout of the insulin receptor. Diabetes53(10), 2645–2652 (2004).
   PubMedGoogle Scholar
• Symons JD, McMillin SL, Riehle C et al. Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure. Circ. Res.104(9), 1085–1094 (2009).
   PubMedGoogle Scholar
• Duncan ER, Crossey PA, Walker S et al. The effect of endothelium specific insulin resistance on endothelial function in vivo. Diabetes57, 3307–3314 (2008).
   PubMed Web of Science ®Google Scholar
• Vicent D, Ilany J, Kondo T et al. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J. Clin. Invest.111, 1373–1380 (2003).
   PubMedGoogle Scholar
• Gage M, Yuldasheva N, Jackson C et al. Endothelial specific insulin resistance promotes the development of atherosclerosis. Circulation122(A17990), 11 (2010).
   PubMedGoogle Scholar
• Rask-Madsen C, Li Q, Freund B et al. Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab.11, 379–389 (2010).
   PubMed Web of Science ®Google Scholar
• Alp NJ, Channon KM, Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler. Thromb. Vasc. Biol.24, 413–420 (2004).
   PubMed Web of Science ®Google Scholar
• Alp NJ, Mussa S, Khoo J et al. Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J. Clin. Invest.112, 725–735 (2003).
   PubMed Web of Science ®Google Scholar
• Silver AE, Beske SD, Christou DD et al. Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress. Circulation115, 627–637 (2007).
   PubMed Web of Science ®Google Scholar
• Fortuño A, San José G, Moreno MU et al. Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome. Diabetes55(1), 209–215 (2006).
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Mussa S, Gastaldi D et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation105, 1656–1662 (2002).
   PubMed Web of Science ®Google Scholar
• Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med.192, 1001–1014 (2000).
   PubMed Web of Science ®Google Scholar
• Dimmeler S. Zeiher AM. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J. Mol. Med.82, 671–677 (2004).
   PubMed Web of Science ®Google Scholar
• Heida NM, Müller JP, Cheng IF. Effects of obesity and weight loss on the functional properties of early outgrowth endothelial progenitor cells. J. Am. Coll. Cardiol.55, 357–367 (2010).
   PubMedGoogle Scholar
• Tobler K, Freudenthaler A, Baumgartner-Parzer SM et al. Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity. Int. J. Obes.34, 687–700 (2010).
   PubMed Web of Science ®Google Scholar
• Sorrentino SA, Bahlmann FH, Besler C et al. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with Type 2 diabetes mellitus – restoration by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. Circulation117(10), 163–173 (2007).
   Google Scholar
• Tepper OM, Galiano RD, Capla JM et al. Human endothelial progenitor cells from Type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation106(22), 2781–2786 (2002).
   PubMed Web of Science ®Google Scholar
• Ii M, Takenaka H, Asai J et al. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in re-endothelialization following arterial injury. Circ. Res.98(5), 697–704 (2006).
   PubMed Web of Science ®Google Scholar
• Kahn MB, Yuldasheva NY, Cubbon RM et al. Insulin resistance impairs circulating angiogenic progenitor cell function and delays endothelial regeneration. Diabetes DOI: 10.2337/db10-1080 (2011) (Epub ahead of print).
   Google Scholar
• Cubbon RM, Cubbon RM, Wheatcroft SB et al. Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur. Heart J.28(5), 540–545 (2007).
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Miller ME, Gerstein HC et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in Type 2 diabetes. N. Engl. J. Med.358(24), 2545–2559 (2008).
   PubMed Web of Science ®Google Scholar
• Patel A, MacMahon S, Chalmers J et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with Type 2 diabetes. N. Engl. J. Med.358, 2560–2572 (2008).
   PubMed Web of Science ®Google Scholar